Evidence map›Paper›PMID 31762722›Full record

ArticleEXCLI journal2019

Increased liver injury in patients with chronic hepatitis and IgG directed against hepatitis E virus.

Daouda Sévédé, Moussa Doumbia, Viviane Kouakou, Vicky Djehiffe, Pascal Pineau, Mireille Dosso

Open access · greenAbstract read
In one paragraph

Article in EXCLI journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. HEV and HBV Dual Infection: A Review.Journal of clinical and translational hepatology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Daouda SévédéDépartement de Bactériologie Virologie, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Moussa DoumbiaDépartement de Bactériologie Virologie, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Viviane KouakouDépartement de Bactériologie Virologie, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Vicky DjehiffeDépartement de Bactériologie Virologie, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Pascal PineauUnité "Organisation nucléaire et Oncogenèse", INSERM U993, Institut Pasteur, Paris, France.
Mireille DossoDépartement de Bactériologie Virologie, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type-E hepatitis is responsible for more than three million symptomatic cases and more than 40,000 deaths worldwide. The situation of this hepatitis is overall poorly known in sub-Saharan Africa. Notably, the baseline circulation of HEV outside sporadic outbreaks has been barely characterized in this large region. More specifically, the impact of superinfection by this virus on the health status of the large reservoir of patients chronically infected with other hepatitis viruses remains to be evaluated. We searched for anti-HEV immunoglobulins in a series of 200 pregnant women and 92 patients with persistent liver infections with hepatitis B or C viruses and subsequently tried to assess serological co-variations with demographical and clinical features. We observed that only 1.5 % of expectant mothers were seropositive of anti-HEV IgG while it was the case for 18.4 % of patients with chronic liver diseases (P=4.5E-07). The presence of anti-HEV was not linked to any of the collected demographical features (age, sex, education, pork meat consumption, water supply, …). By contrast, the presence of anti-HEV was significantly associated with increased levels (1.6-1.8-fold, P<0.0001) of blood aminotransferases (AST, ALT) in patients with persistent hepatitis B or C. Our work indicates that, in Ivory Coast, the presence of IgG directed against HEV might contribute to a deterioration of liver health in patients with already installed persistent liver infections. The mechanisms explaining such phenomenon at distance of acute phase of infection are still unknown but might be linked either to a residual persistence of HEV in a context of general immune exhaustion or to an inappropriate auto-immune reaction as already observed in the aftermath of other viral infection types.

Indexed as

aggravation of liver damageCôte d'Ivoirehepatitis E virusseropositivity

Identifiers

PMID31762722
PMCPMC6868915
OpenAlexW3022460184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.